Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Safeplus International Holdings Limited (ACAI : OTC)
 
 • Company Description   
Biophan Technologies is engaged in designing, developing, and marketing new technology and related products to enable cardiac pacemakers and other life sustaining medical devices to be safe and compatible with magnetic resonance imaging (MRI) and other equipment using magnetic fields and radio waves. This MRI-compatible technology will be utilized in implantable pacemakers, implantable cardioverter defibrillators, and other medical equipment.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.15 Daily Weekly Monthly
20 Day Moving Average: 350 shares
Shares Outstanding: 5.38 (millions)
Market Capitalization: $0.81 (millions)
Beta: 0.73
52 Week High: $2.29
52 Week Low: $0.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -39.54% -34.00%
12 Week 8.86% 17.65%
Year To Date -13.66% 2.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
15 SCHOEN PLACE
-
PITTSFORD,NY 14534
USA
ph: 585-267-4800
fax: 585-427-2433
info@biophan.com http://www.biophan.com
 
 • General Corporate Information   
Officers
Stan Yakatan - Chairman
John F. Lanzafame - Chief Executive Officer
Margaret V. Russell - Chief Financial Officer
Theodore A. Greenberg - Director
Harold Gubnitsky - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 78646R106
SIC: 3841
Fiscal Year
Fiscal Year End: February
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 5.38
Most Recent Split Date: 9.00 (0.01:1)
Beta: 0.73
Market Capitalization: $0.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
02/28/22 - -
11/30/21 - -
08/31/21 - -
ROA
02/28/22 - -
11/30/21 - -
08/31/21 - -
Current Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Quick Ratio
02/28/22 - -
11/30/21 - -
08/31/21 - -
Operating Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Net Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Pre-Tax Margin
02/28/22 - -
11/30/21 - -
08/31/21 - -
Book Value
02/28/22 - -
11/30/21 - -
08/31/21 - -
Inventory Turnover
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Equity
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Capital
02/28/22 - -
11/30/21 - -
08/31/21 - -
 

Powered by Zacks Investment Research ©